Cargando…

Whose Elimination? Frontline Workers’ Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences

While academic literature has paid careful attention to the technological efforts―drugs, tests, and tools for vector control―deployed to eliminate Gambiense Human African Trypanosomiasis (HAT), the human resources and health systems dimensions of elimination are less documented. This paper analyses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falisse, Jean-Benoît, Mwamba-Miaka, Erick, Mpanya, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157216/ https://www.ncbi.nlm.nih.gov/pubmed/31906341 http://dx.doi.org/10.3390/tropicalmed5010006

Ejemplares similares

Village-scale persistence and elimination of gambiense human African trypanosomiasis
por: Davis, Christopher N., et al.
Publicado: (2019)

Modelling to infer the role of animals in gambiense human African trypanosomiasis transmission and elimination in the DRC
por: Crump, Ronald E., et al.
Publicado: (2022)

Modelling to Quantify the Likelihood that Local Elimination of Transmission has Occurred Using Routine Gambiense Human African Trypanosomiasis Surveillance Data
por: Davis, Christopher N, et al.
Publicado: (2021)

Innovative digital technologies for quality assurance of diagnosis of human African trypanosomiasis
por: Hasker, Epco, et al.
Publicado: (2018)

Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2020)

Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2021)

The elimination of human African trypanosomiasis is in sight: Report from the third WHO stakeholders meeting on elimination of gambiense human African trypanosomiasis
por: Barrett, Michael P.
Publicado: (2018)

Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis
por: Gilbert, Jennifer A., et al.
Publicado: (2016)

Monitoring the elimination of human African trypanosomiasis: Update to 2016
por: Franco, José R., et al.
Publicado: (2018)

Monitoring the elimination of human African trypanosomiasis: Update to 2014
por: Franco, José R., et al.
Publicado: (2017)

Gambiense human African trypanosomiasis: the bumpy road to elimination
por: Hasker, Epco, et al.
Publicado: (2022)

The Flipside of Eradicating a Disease; Human African Trypanosomiasis in a Woman in Rural Democratic Republic of Congo: A Case Report
por: Mudji, Junior, et al.
Publicado: (2019)

Is vector control needed to eliminate gambiense human African trypanosomiasis?
por: Solano, Philippe, et al.
Publicado: (2013)

Monitoring the Progress towards the Elimination of Gambiense Human African Trypanosomiasis
por: Simarro, Pere P., et al.
Publicado: (2015)

Understanding the Role of the Diagnostic ‘Reflex’ in the Elimination of Human African Trypanosomiasis
por: Palmer, Jennifer J., et al.
Publicado: (2020)

Innovative Partnerships for the Elimination of Human African Trypanosomiasis and the Development of Fexinidazole
por: Neau, Philippe, et al.
Publicado: (2020)

Product Development Partnerships: Delivering Innovation for the Elimination of African Trypanosomiasis?
por: Taylor, Emma Michelle, et al.
Publicado: (2020)

Cost-effectiveness modelling to optimise active screening strategy for gambiense human African trypanosomiasis in endemic areas of the Democratic Republic of Congo
por: Davis, Christopher N., et al.
Publicado: (2021)

First WHO Meeting of Stakeholders on Elimination of Gambiense Human African Trypanosomiasis
por: Holmes, Peter
Publicado: (2014)

Quantifying epidemiological drivers of gambiense human African Trypanosomiasis across the Democratic Republic of Congo
por: Crump, Ronald E., et al.
Publicado: (2021)

Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Inocencio da Luz, Raquel, et al.
Publicado: (2021)

On the Road to Elimination of Rhodesiense Human African Trypanosomiasis: First WHO Meeting of Stakeholders
por: Holmes, Peter
Publicado: (2015)

Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo
por: Rock, Kat S., et al.
Publicado: (2015)

Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018
por: Franco, José R., et al.
Publicado: (2020)

A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC
por: Huang, Ching-I, et al.
Publicado: (2023)

Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo
por: Tirados, Inaki, et al.
Publicado: (2020)

Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next>
por: Simarro, Pere P, et al.
Publicado: (2008)

Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis
por: Ilboudo, Hamidou, et al.
Publicado: (2017)

The elimination of human African trypanosomiasis: Achievements in relation to WHO road map targets for 2020
por: Franco, Jose R., et al.
Publicado: (2022)

Predicting the impact of COVID-19 interruptions on transmission of gambiense human African trypanosomiasis in two health zones of the Democratic Republic of Congo
por: Aliee, Maryam, et al.
Publicado: (2021)

Challenges towards the elimination of Human African Trypanosomiasis in the sleeping sickness focus of Campo in southern Cameroon
por: Simo, Gustave, et al.
Publicado: (2014)

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
por: Dama, Emilie, et al.
Publicado: (2019)

Economic evaluation of disease elimination: An extension to the net-benefit framework and application to human African trypanosomiasis
por: Antillon, Marina, et al.
Publicado: (2021)

WHO target product profiles: four diagnostic tests needed in the effort to eliminate African trypanosomiasis
por: Priotto, Gerardo, et al.
Publicado: (2023)

Cost-effectiveness of sleeping sickness elimination campaigns in five settings of the Democratic Republic of Congo
por: Antillon, Marina, et al.
Publicado: (2022)

Livestock, pathogens, vectors, and their environment: A causal inference-based approach to estimating the pathway-specific effect of livestock on human African trypanosomiasis risk
por: Meisner, Julianne, et al.
Publicado: (2023)

Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
por: Compaoré, Charlie Franck Alfred, et al.
Publicado: (2022)

Health economic evaluation of strategies to eliminate gambiense human African trypanosomiasis in the Mandoul disease focus of Chad
por: Antillon, Marina, et al.
Publicado: (2023)

Towards the sustainable elimination of gambiense human African trypanosomiasis in Côte d’Ivoire using an integrated approach
por: Kaba, Dramane, et al.
Publicado: (2023)

Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa
por: Sutherland, C Simone, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nel6sqjnk9mjjshc570hjlgov1